Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Change in Receivables (2022 - 2025)

Historic Change in Receivables for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $27121.0.

  • bioAffinity Technologies' Change in Receivables rose 11010.25% to $27121.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$878178.0, marking a year-over-year decrease of 41821.73%. This contributed to the annual value of $327530.0 for FY2024, which is 20519.13% up from last year.
  • Latest data reveals that bioAffinity Technologies reported Change in Receivables of $27121.0 as of Q3 2025, which was up 11010.25% from -$541875.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Change in Receivables peaked at $472017.0 during Q2 2024, and registered a low of -$541875.0 during Q2 2025.
  • Moreover, its 4-year median value for Change in Receivables was $559.0 (2022), whereas its average is -$44339.4.
  • Per our database at Business Quant, bioAffinity Technologies' Change in Receivables tumbled by 4294901.61% in 2023 and then surged by 5788048.33% in 2024.
  • bioAffinity Technologies' Change in Receivables (Quarter) stood at $559.0 in 2022, then tumbled by 42949.02% to -$239526.0 in 2023, then rose by 21.53% to -$187964.0 in 2024, then soared by 114.43% to $27121.0 in 2025.
  • Its Change in Receivables stands at $27121.0 for Q3 2025, versus -$541875.0 for Q2 2025 and -$175460.0 for Q1 2025.